Multivisceral surgery for advanced gynaecological malignancies

European Surgery - Acta Chirurgica Austriaca

Volumn 35, Issue 2, 2003, Pages 102-105

  Weidemann, H ^a   Hieronimus Reichel, A ^a   Sehouli, J ^a   Platz, K P ^a   Buchmann, E ^a   Heider, B ^a   Lichtenegger, W ^a   Loening, S A ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cervical cancer; Multivisceral surgery; Recurrent gynaecological cancer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC CANCER; HUMAN; MORBIDITY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT INDICATION; UTERINE CERVIX CANCER;

EID: 0037738486     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1682-4016.2003.03046.x     Document Type: Article

References (32)

1. Barber HR: Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg Clin North Am 1969;49:431-447.
2. Barber HR, Brunschwig A: Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration 1947-1963. Cancer 1968;22:949-955.
3. Barber HRK, Jones W: Lymphadenectomy in pelvic exenteration for recurrent Zervix cancer. JAMA 1971;215:1945-1949.
4. Bastert G, Wallwiener D 1996: Aktuelle Aspekte der gynäkologischen Onkologie an der Jahrtausendwende. Onkologe 2:25-30.
5. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ: Stage IVb endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 2000;78:85-91.
6. Brophy PF, Hoffman JP, Eisenberg BL: The role of palliative pelvic exenteration. Am J Surg 1994;167:386-390.
7. Deckers P, Olsson C, Williams LA, Mozden PJ: Pelvic exenteration as palliation of malignant disease. Am J Surg 1976;131:509-515.
8. Finlayson CA, Eisenberg BL: Palliative pelvic exenteration: patient selection and results. Oncology (Huntingt) 1996;10:479-486, 490, 493.
9. Jänicke F: Das fortgeschrittene Ovarialkarzinom. Dt Arztebl 1999;96:281-288.
10. Jones WB: Surgical approaches for advanced or recurrent cancer of the cervix. Cancer 1987;60:2094-2103.
11. Kiselow M, Butcher HR, Bricker EM: Results of the radical surgical treatment of advanced pelvic cancer: a fifteen year study. Ann Surg 1967;166:428-436.
12. Kreienberg R, Höckel M, Klose KJ, Friedberg V: Therapeutische Möglichkeiten beim Rezidiv des Zervixkarzinoms. In: Meerpohl HG, Pfleiderer A, Profous CZ (Hrsg.): Das Rezidiv in der gynäkologischen Onkologie. Berlin, Springer-Verlag, 1990, pp 169-181.
13. Lichtenegger W, Sehouli J, Buchmann E, Karajanev C, Weidemann H: Operative results after primary and secondary debulking-operations in advanced ovarian cancer. J Obstet Gyn Res 1998;24:447-451.
14. Mattingly RF: Total pelvic evisceration. Clin Obstet Gynec 1965;8:705-725.
15. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA: Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-943.
16. Morley GW, Lindenauer SM: Pelvic exenterative therapy for gynecologic malignancy: an analysis of 70 cases. Cancer 1976;38:581-586.
17. Morley GW, Lindenauer SM, Cerny JC: Pelvic exenterative therapy in recurrent pelvic carcinoma. Am J Obstet Gynecol 1971;109:1175-1186.
18. Numa F, Ogata H, Suminami Y, Tsunaga N, Nakamura Y, Tamura H, Takasugi N, Kato H, Tangoku A, Uchiyama T, Oka M, Suzuki T, Yamamoto M, Naito K: Pelvic exenteration for the treatment of gynecological malignancies. Arch Gynecol Obstet 1997;259:133-138.
19. Pfleiderer A: Maligne Ovarialtumoren. In: Martius G, Breckwoldt M, Pfleiderer A (Hrsg.): Lehrbuch der Gynäkologie und Geburtshilfe. Stuttgart, Thieme Verlag, 1994, pp 526-534.
20. Ricke J, Sehouli J, Hosten N, Stroszcynski C, Amthauer H, Rieger J, Buchmann E, Felix R: Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;171:461-467.
21. Rutledge FN, Burns BC: Pelvic exenteration. Am J Obstet Gynecol 1965;91:692-708.
22. Rutledge FN, Smith JP, Wharton JT, O'Quinn AG: Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-892.
23. Scarabelli C, Campagnutta E, Giorda G, DePiero G, Sopracordevole F, Quaranta M, DeMarco L: Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma. Gynecol Oncol 1998;70:90-93.
24. Schlag PM, Graschew G, Engel-Murke F: Vision chirurgisch-onkologischer Eingriffe Onkologie 1996;2:10-14.
25. Sounders N: Pelvic exenteration: by whom and for whom? Lancet 1995;345:5-6.
26. Stanhope CR, Symmonds RE: Palliative exenteration - what, when and why? Am J Obstet Gynecol 1985;152:12-16.
27. Symmonds RE, Pratt JH, Webb MJ: Exenterative operations: experience with 198 patients. Am J Obstet Gynecol 1975;121:907-918.
28. Valle G, Ferraris G: Use of the omentum to contain the intestines in pelvic exenteration. Obstet Gynecol 1969;33:772-775.
29. Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC: Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 1987;205:482-494.
30. Webb MJ, Symmonds RE: Management of pelvic floor after pelvic exenteration. Obstet Gynecol 1977;50:166-171.
31. Weidemann H, Müller AR, Kratschmer B, Neuhaus P: Die Beckenbodenplastik in der Tumorchirurgie durch gestielte intestinale Transplantate. Coloproctology 1998;20:123-127.
32. Yeung RS, Moffat FL, Falk RE: Pelvic exenteration for recurrent colorectal carcinoma: a review. Cancer Invest 1994;12:176-188.